Compare
LeMaitre Vascular vs Medtronic (LMAT vs MDT)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year LeMaitre Vascular (LMAT) returned -6.2% and Medtronic (MDT) +12.6%; so far this year the figures are -0.3% and +6.0%.
Medtronic is the larger company by market value, about 70.4 times the size of LeMaitre Vascular.
On trailing earnings, LMAT trades at 29.4 times and MDT at 25.0 times.
Revenue grew +11.8% at LMAT and +9.8% at MDT over the last year.
LMAT yields 1.17%. MDT yields 2.81%.
Data as of the latest close. Not investment advice.
Relative performance
| LMAT | MDT | |
|---|---|---|
| Price | $80.89 | $101.80 |
| 1-day | -3.11% | -2.90% |
| YTD | -0.26% | +5.98% |
| 1 year | -6.24% | +12.61% |
| 3 years | +69.16% | +43.68% |
| Market cap | $1.9B | $130.2B |
| P/E | 29.4 | 25.0 |
| P/S | 6.87 | 3.47 |
| P/B | 4.28 | 2.59 |
| Revenue growth | +11.80% | +9.80% |
| EPS growth | +19.00% | +12.10% |
| Gross margin % | 72.0 | 65.0 |
| Net margin % | 23.5 | 13.9 |
| ROE % | 14.7 | 10.4 |
| Debt / equity | 0.00 | 0.56 |
| FCF yield % | 3.6 | 4.7 |
| Dividend yield % | 1.17 | 2.81 |
| Beta | 0.62 | 0.14 |
| RSI (14) | 46.5 | 63.8 |
| Technical rating |